KARACHI: In response to inquiries from the Pakistan Stock Exchange (PSX) regarding unusual movements in its stock price, GlaxoSmithKline Pakistan Limited has confirmed that there are no undisclosed issues influencing its recent market performance. The company's statement on October 4, 2024, follows a request for information by the PSX after noticeable fluctuations were observed in GlaxoSmithKline’s share prices.

According to information available from the Pakistan Stock Exchange (PSX), the company’s spokesperson, Hina Mir, clarified in a letter to the PSX that all substantial developments that could affect the company's stock have already been disclosed through Pakistan's Unified Corporate Reporting System (PUCARS). This platform ensures transparency by allowing companies to disseminate essential financial and corporate information to the public and regulatory bodies.

GlaxoSmithKline Pakistan Limited reiterated its commitment to maintaining rigorous compliance with market regulations and continues to operate with the highest levels of corporate governance and transparency.